- JP-listed companies
- J Frontier Co.,Ltd.
- Income statement
J Frontier Co.,Ltd. (2934) Income statement
Market cap
¥9B
P/E ratio
87.3x
J-Frontier develops and sells health supplements and pharmaceuticals while operating SOKUYAKU, a medical platform for online consultations and prescription delivery.
| 2016/05 | 2017/05 | 2018/05 | 2019/05 | 2020/05 | 2021/05 | 2022/05 | 2023/05 | 2024/05 | 2025/05 | 2026/05 | |
| Revenue | 2,025 | 4,000 | 5,198 | 6,126 | 7,106 | 8,493 | 11,877 | 16,845 | 17,715 | 21,504 | 22,235 |
| Revenue growth (%) | - | ||||||||||
| Cost of revenue | - | - | - | 972 | 1,611 | 1,864 | 6,477 | 9,728 | 9,382 | 11,931 | 13,256 |
| Gross profit | - | - | - | 5,153 | 5,495 | 6,629 | 5,399 | 7,117 | 8,333 | 9,574 | 8,980 |
| Gross margin (%) | - | - | - | ||||||||
| Operating margin (%) | - | - | - | ||||||||
| Operating expenses | - | - | - | 4,785 | 5,324 | 5,957 | 4,667 | 8,933 | 8,886 | 9,280 | 8,668 |
| Operating income | - | - | - | 368 | 170 | 672 | 732 | -1,816 | -553 | 294 | 312 |
| Income before tax | 51 | 518 | 589 | 367 | 174 | 679 | 713 | -1,841 | -643 | 232 | 415 |
| Pretax margin (%) | 2.5 | 12.9 | 11.3 | 6 | 2.5 | 8 | 6 | -10.9 | -3.6 | 1.1 | 1.9 |
| Provision for income taxes | - | - | - | 105 | 39 | 254 | 301 | 21 | 370 | 117 | 175 |
| Effective tax rate (%) | - | - | - | ||||||||
| Net income | 24 | 322 | 399 | 6 | 96 | 425 | 401 | -1,867 | -2,030 | 132 | -638 |
| Earnings per share | 6,366.95 | 83,827.28 | 207.98 | 1.6 | 25.12 | 110.75 | 90.64 | -410.6 | -426.06 | 17.42 | -60.64 |
| Diluted EPS | - | - | - | - | - | - | 86.68 | - | - | 17.21 | - |
| Dividend payout ratio (%) | - | - | - | - | - | - | - | - | - | - | - |
| Dividend per share | - | - | - | - | - | - | - | - | - | - | - |